Zhitong Financial APP News, Lanwei Medicine (301060.SZ) released a report for the third quarter of 2023, with operating income of 1.27 billion yuan in the first three quarters, down 59.15% from the same period last year. The net loss of the shareholders belonging to the listed company is 880100 yuan. The net loss after deducting non-recurrent profit and loss belonging to the shareholders of the listed company is 14.174 million yuan.
兰卫医学(301060.SZ)发布前三季业绩，净亏损88.01万元
Lanwei Medical (30100.SZ) released the first three quarter results, with a net loss of 881,000 yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.